SUMMARY A patient with hypertrophic cardiomyopathy, syncope, and frequent ventricular tachycardia was monitored during a syncopal episode. An unrecordable blood pressure and the loss of a left ventricular outflow tract murmur without evidence of arrhythmia suggested a primary haemodynamic mechanism such as reduction in left ventricular volume.
Death is often sudden in hypertrophic cardiomyopathyl and is associated with syncope2 and serious ventricular arrhythimia.3 Though While she was waLking in the hospital accompanied by one of us (WM) the patient complained of palpitation and breathlessness. The pulse was found to be rapid and jerky and a systolic murmur was present. Though the patient sat down, the symptoms persisted. Over a period of two minutes the pulse became impalpable, the murmur disappeared, and the patient then lost consciousness. Despite external cardiac massage peripheral pulses were not palpable and signs of anoxia developed. She remained unconscious for 90 seconds, after which she recovered spontaneously with a gradual restoration of the peripheral pulses and the systolic murmur. There were no neurological sequelae. During this episode the patient was wearing an electrocardiographic recorder. This disclosed an increasing sinus rate over three minutes, beats/minute at the time that she lost consciousness Within three minutes the electrocardiogram had (Fig. 2) . During the recovery period, ST segment returned to the baseline pattern. depression was more pronounced and she showed The patient was started on verapamil 120 mg daily. atrioventricular dissociation with an accelerated junc-After three days, however, she complained of more tional rhythm of 50 beats/minute and occasional frequent episodes of palpitation, breathlessness, chest fusion beats (Fig. 2) ; the sinus rate gradually acceler-heaviness, and dizziness and she was found to be in ated with a return to normal sinus rhythm (70 beats/ pulmonary oedema. Verapamil was discontinued, the minute) but with pronounced ST depression (Fig. 2) . pulmonary oedema cleared, and amiodarone was started with a loading dose of 1200 mg daily for one week followed by a maintenance dose of 400 mg daily. The patient improved and four months later she remains well and has had no palpitation or syncope. She continues to experience breathlessness and heaviness in the chest on effort. Seventy-two hour ambulatory electrocardiographic monitoring disclosed no ventricular tachycardia and a peak hourly and daily ventricular extrasystole count of three and nine, respectively. Treadmill exercise testing was repeated and she exercised for nine minutes, completing stage three of the Bruce protocol without distress.
Discussion
This patient has hypertrophic cardiomyopathy with rapidly progressive symptoms, syncope, and ventricular tachycardia; all features that are associated with poor prognosis.2 3 Though it is logical to assume that syncopal episodes may be caused by arrhythmia this patient demonstrates that this need not be so. 
